Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hepatitis × Mycophenolic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 116 Precursor Cell Lymphoblastic Leukemia-Lymphoma 102 Myelodysplastic Syndromes 96 Leukemia, Lymphocytic, Chronic, B-Cell 88 Lymphoma, Non-Hodgkin 86 Hodgkin Disease 80 Leukemia 74 Multiple Myeloma 71 Lymphoma 60 Lymphoma, Mantle-Cell 59 Lymphoma, Follicular 58 Lymphoma, Large B-Cell, Diffuse 56 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 54 Lymphoma, B-Cell, Marginal Zone 51 Myeloproliferative Disorders 50 Burkitt Lymphoma 47 Leukemia, Myelomonocytic, Chronic 45 Leukemia, Myeloid, Chronic-Phase 42 Congenital Abnormalities 42 Lymphoma, Large-Cell, Immunoblastic 41 Leukemia, Myeloid, Accelerated Phase 37 Hematologic Neoplasms 36 Anemia, Refractory, with Excess of Blasts 34 Primary Myelofibrosis 33 Graft vs Host Disease 32 Waldenstrom Macroglobulinemia 29 Blast Crisis 29 Dendritic Cell Sarcoma, Interdigitating 28 Lymphoma, T-Cell, Cutaneous 27 Leukemia, Biphenotypic, Acute 27

Interventions

bavituximab 1 Ursodeoxycholic Acid 1 Steroids 1 Sorafenib 1 Sofosbuvir 1 Ribavirin 1 Prednisone 1 Mycophenolic Acid 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Adrenal Cortex Hormones 1 3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡